Initial characterization of hamsters with spontaneous hypertension

Hypertension

Volumn 30, Issue 2, 1997, Pages 301-304

  Thomas, Crystal L ^a   Artwohl, James E ^a   Suzuki, Hideyuki ^b   Gao, Xiao Pei ^b   White, Edward ^c   Saroli, Andres ^c   Bunte, Ralph M ^a   Rubinstein, Israel ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c Canadian Hybrid Farms   (Canada)

Author keywords

Blood pressure; Essential; Hamsters; Hypertension; Hypertrophy; Left ventricular; Leukocytes; Plasma renin activity

Indexed keywords

RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; HAMSTER; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; INBRED STRAIN; MEAN ARTERIAL PRESSURE; NEUTROPHIL; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; QRS COMPLEX;

EID: 0030792021     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.2.301     Document Type: Article

References (31)

1. Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure. The 1988 report of the Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med. 1988;148:1023-1038.
2. Falkner B. Differences in blacks and whites with essential hypertension: biochemistry and endocrine. Hypertension. 1990;15:681-686.
3. Koletsky S, Shook P, Rivera-Velze J. Lack of increased renin-angiotensin activity in rats with spontaneous hypertension. Proc Soc Exp Biol Med. 1970;134:1187-1190.
4. Pham I, Gonzalez W, El Amrani A-IK, Fournié-Zaluski M-C, Philippe M, Laboulandine I, Roques BP, Michel J-B. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension. J Pharmacol Exp Ther. 1993;265:1339-1347.
5. Vera Gonzalez W, Fournié-Zaluski M-C, Pham I, Laboulandine I, Roques B-P, Michel J-B. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats. J Pharmacol Exp Ther. 1995;272:343-351.
6. Pfeffer JM, Pfeffer M, Mirsky I, Braunwald E. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc Natl Acad Sci USA. 1982;79:3310-3314.
7. Dahl LK. Effects of chronic salt feeding on induction of self-sustaining hypertension in rats. J Exp Med. 1961;114:231-236.
8. Roques BP, Noble F, Dauge V, Fournié-Zaluski M-C, Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev. 1993;45:87-146.
9. Hirata Y, Suzuki Y, Suzuki E, Hayakawa H, Kimura K, Goto A, Omata M, Minamino N, Kangawa K, Matsuo H. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors. J Hypertens. 1994;12:367-374.
10. Jin H, Mathews C, Chen Y-F, Yang R, Wyss JM, Esunge P, Oparil S. Effects of acute and chronic blockade of neutral endopeptidase with Sen 34826 on NaCl-sensitive hypertension in spontaneously hypertensive rats. Am J Hypertens. 1992;5:210-218.
11. Seymour AA, Swerdel JN, Abboa-Offei B. Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme. J Cardiovasc Pharmacol. 1991;17:456-465.
12. Koepke JP, Tyler LD, Blehm DJ, Shuh JR, Blaine EH. Chronic atriopeptin regulation of arterial pressure in conscious hypertensive rats. Hypertension. 1990;16:642-647.
13. Lindpaintner K, Kreutz R, Ganten D. Genetic variation in hypertensive and 'control' strains: what are we controlling for anyway? Hypertension. 1992;19:428-430.
14. Rubinstein I, Mayhan WG. L-arginine dilates cheek pouch arterioles in hamsters with hereditary cardiomyopathy. J Lab Clin Med. 1995;125:313-318.
15. Rubinstein I, Gao X-p, Engel JA, Vishwanatha JK. Tissue angiotensin I-converting enzyme activity in ageing hamsters with and without cardiomyopathy. Mech Ageing Dev. 1995;78:163-170.
16. Suzuki H, Noda Y, Gao X-p, Séjourné F, Alkan-Önyüksel H, Paul S, Rubinstein I. Encapsulation of vasoactive intestinal peptide into liposomes restores vasorelaxation in hypertension in situ. Am J Physiol. 1996;271:H282-H287.
17. Rubinstein I, Houmsse M, Davis RG, Vishwanatha JK. Tissue angiotensin I-converting enzyme activity in spontaneously hypertensive hamsters. Biochem Biophys Res Commun. 1992;183:1117-1123.
18. Gao X-p, Anding P, Robbins RA, Rennard SI, Rubinstein I. Peptidases modulate bradykinin-induced arteriolar dilatation in the hamster cheek pouch. Am J Physiol. 1994;266:H93-H98.
19. Click MJ, Gilmore JP, Joyner WL. Direct demonstration of alterations in the microcirculation of the hamster during and following renal hypertension. Circ Res. 1977;41:461-467.
20. Joyner WL, Davis MJ, Gilmore JP. Intravascular pressure distribution and dimensional analysis of microvessels in hamsters with renovascular hypertension. Microvasc Res. 1981;22:190-198.
21. Kutscher C. Plasma volume change during water-deprivation in gerbils, hamsters, guinea pigs and rats. Comp Biochem Physiol. 1968;25:929-936.
22. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev. 1992;44:1-80.
23. Schulz R, Sakane Y, Berry C, Ghai R. Characterization of neutral endopeptidase 3.4.24.11 (NEP) in the kidney: comparison between normotensive, genetically hypertensive and experimentally hypertensive rats. J Enzym Inhib. 1991;4:347-358.
24. Phillips MI, Speakman EA, Kimura B. Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept. 1993;43:1-20.
25. Schmid-Schönbein GW, Seiffge D, DeLano FA, Shen K, Zweifach BW. Leukocyte counts and activation in spontaneously hypertensive and normotensive rats. Hypertension. 1991;17:323-330.
26. Arndt H, Smith CW, Granger DN. Leukocyte-endothelial cell adhesion in spontaneously hypertensive and normotensive rats. Hypertension. 1993;21:667-673.
27. Shen K, DeLano FA, Zweifach BW, Schmid-Schönbein GW. Circulating leukocyte counts, activation and degranulation in Dahl hypertensive rats. Circ Res. 1995;76:276-283.
28. Suematsu M, Suzuki H, Tamatani T, Ligou Y, DeLano FA, Miyasaka M, Forrest MJ, Kannagi R, Zweifach BW, Ishimura Y, Schmid-Schönbein GW. Impairment of selectin-mediated leukocyte adhesion to venular endothelium in spontaneously hypertensive rats. J Clin Invest. 1995;96:2009-2016.
29. Friedman GD, Selby JV, Quesenberry CP Jr. The leukocyte count: a predictor of hypertension. J Clin Epidemiol. 1990;43:907-911.
30. Perich R, Jackson B, Paxton D, Johnston CI. Characterization of angiotensin converting enzyme in isolated cerebral microvessels from spontaneously hypertensive and normotensive rats. J Hypertens. 1992;10:149-153.
31. Assad MM, Antonaccio MJ. Vascular wall renin in spontaneously hypertensive rats: potential relevance to hypertension maintenance and antihypertensive effect of captopril. Hypertension. 1982;4: 487-493.